Andrew J. Barkmeier, M.D., is an ophthalmologist specializing in diseases and surgery of the retina and vitreous. His clinical and research interests include diabetic retinopathy, age-related macular degeneration, retinal vascular disease, telemedicine, and complex vitreoretinal surgery for complications of diabetic retinopathy, ocular trauma, retinal detachment and proliferative vitreoretinopathy.
- Outcomes of surgical and pharmacological management of retinal disease
- Clinical and administrative database research
- Telemedicine and health care delivery
- Clinical trials in diabetic retinopathy and retinal disease
Significance to patient care
Diseases of the macula, retina and vitreous are responsible for the majority of irreversible legal blindness in the United States. Dr. Barkmeier's research aims to better understand how patients respond to current vitreoretinal therapies and to clarify potential risks related to treatment.
His research also involves the use of clinical imaging, retinal screening systems, and population-based and large-scale administrative database resources, with the goal of optimizing surveillance protocols and treatment strategies for patients with sight-threatening retinal disease.
- Recipient, Achievement Award, American Academy of Ophthalmology, 2017
- Recipient, Honor Award, American Society of Retina Specialists, 2016